Prevalence of Carbapenem Resistant Enterobacteriaceae (CRE) Among Patients Admitted to Palestine Red Crescent Society Hospital in Hebron, Palestine

Amal M. Dofesh*

Carbapenem-Resistant Enterobacterales (CRE) pose a significant threat to global healthcare due to limited treatment options and high morbidity and mortality rates. Our study, conducted at Palestine Red Crescent Society Hospital, investigated the prevalence and acquisition dynamics of CRE colonization among patients from 2020 to 2023. Of the 5,445 patients, 219 met the inclusion criteria, with CRE prevalence varying annually (4.3%-6.28%). Notably, 22.7%-57.1% of patients exhibited CRE colonization upon admission, and 43.9%-77.2% acquired CRE during hospitalization. Comparatively, 24.0%-76.0% of patients acquired multidrug-resistant MDR bacteria. Our findings emphasize the need for vigilant monitoring and infection control measures to curb CRE transmission in healthcare settings.

Published Date: 2023-10-26; Received Date: 2023-09-24